- Home
- VCYT vs NFEGP Comparison
VCYT vs NFEGP Comparison
Compare VCYT & NFEGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$44.68
Company Overview
Basic Information| Metric | VCYT | NFEGP |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.9B |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VCYT | NFEGP |
|---|---|---|
| Price | $44.68 | $400.00 |
| Analyst Decision | Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $58.42 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 5.2K |
| Earning Date | 11-03-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | N/A | ★ $1,504,037,000.00 |
| Revenue This Year | $14.82 | N/A |
| Revenue Next Year | $11.24 | N/A |
| P/E Ratio | $70.03 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.46 | $350.00 |
| 52 Week High | $60.91 | $514.99 |
Technical Indicators
Market Signals| Indicator | VCYT | NFEGP |
|---|---|---|
| Relative Strength Index (RSI) | 54.89 | 8.70 |
| Support Level | $40.03 | N/A |
| Resistance Level | $50.54 | N/A |
| Average True Range (ATR) | 2.40 | 26.67 |
| MACD | 0.71 | -11.73 |
| Stochastic Oscillator | 70.80 | 30.30 |
Price Performance
Historical Comparison VCYT
NFEGP
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).